• Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus
1979 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Area of Expertise

Currently there are no clinically-effective treatments or prophylactic-preventative agents for Alzheimer’s disease (AD). My current research involves identification of molecular mechanisms of neuronal cell death in AD and developing cost-effective, clinically-useful drug therapies for prevention of neuronal cell death and the treatment of AD. We are testing the effects of drugs that prevent neuronal cell death and improve memory in the genetically-engineered mouse model of AD. The identification of novel pathways that these potential drugs regulate for neuroprotection in these genetically-engineered mice, could provide new therapeutic avenues for AD. The anticipated outcomes of our mouse studies are likely to provide strong justification for the continued development and future clinical trials of these drugs for the treatment of AD.

Education/Academic qualification

Bachelor in Mathematics, University of Calcutta

MS in Chemistry, University of Calcutta

PhD, University of Nebraska

Fingerprint

Dive into the research topics where Hriday Das is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.
If you made any changes in Pure these will be visible here soon.